Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03677141 |
|---|---|
| Brief Title: | A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma |
| First Submitted : | September 11, 2018 |
| First Submitted that Met QC Criteria : | September 17, 2018 |
| First Posted : | September 19, 2018 |
| Last Update Submitted that Met QC Criteria : | February 16, 2023 |
| Last Update Posted : | February 17, 2023 |